Find Academic Supervisors

• Epidemiology
• Haematology
• Implementation Science
• +4 more

Dr Yusuf Adelabu is a Nigerian Clinical Haematologist and Lecturer at the University of Lagos' Department of Medicine. He also pursues a PhD at the London School of Hygiene & Tropical Medicine in Infectious Disease Epidemiology and International Health. With a medical degree from the University of Lagos and a Clinical Haematology fellowship from the National Postgraduate Medical College of Nigeria, Adelabu combines clinical expertise with epidemiological research. Education: MBBS (University of Lagos, 2008); Clinical Haematology Fellowship (2018) Certifications: European Haematology Exam (2018); FMCP (2018) His research focuses on anaemia (particularly pregnancy-related), implementation science in healthcare systems, and haematological malignancies . Publications reveal expertise in: Maternal health interventions Diagnostic challenges in resource-poor settings Environmental health impacts (air pollution, dust exposure) Chronic disease management (sickle cell, glioblastoma) Global health equity Clinical epidemiology His 2025 publications highlight implementation research strategies for anaemia screening and environmental health impacts. Earlier work spans sickle cell disease outcomes (2022), Lassa fever anaemia (2020), and HIV coagulation studies (2019). Scientific Contributions Developed quality improvement protocols for Nigerian maternal anaemia treatment (2023) Advancing prenatal health research (2024) Contributing to international haematology certifications Adelabu teaches haematology , clinical medicine , and clinical skills development to medical students, while maintaining a clinical practice in Lagos.

• Immunology
• T cell biology
• Autoimmune diseases
• +5 more

Professor Hans-Willi Mittrücker is a distinguished immunologist at the Institute for Immunology within the University Hospital Hamburg-Eppendorf (UKE). With over 150 publications to his name, his research focuses on fundamental mechanisms of T cell biology and their implications in autoimmune and infectious diseases. His work spans multiple research areas including kidney inflammation, liver immunology, and pregnancy-related immune responses. His primary research interests include: T cell differentiation and effector functions Interferon regulatory factors in immune responses Purinergic signaling in immune regulation Autoimmune glomerulonephritis Maternal-fetal immune interactions Intestinal immunity and mucosal homeostasis Professor Mittrücker's recent publications demonstrate a strong focus on the molecular mechanisms of T cell memory, cytokine regulation, and the role of specific signaling pathways in autoimmune conditions. His work on interferon regulatory factors, purinergic receptors, and T cell subsets in organ-specific inflammation has provided significant insights into disease pathogenesis and potential therapeutic targets. The research shows a consistent trajectory toward understanding how T cell responses can be modulated in various disease contexts, with implications for developing targeted immunotherapies. Professor Mittrücker has secured substantial research funding through multiple German Research Foundation (DFG) projects, including: SFB 1328 A03: Regulation of T cell differentiation and effector functions by adenine nucleotides (2018-2022) MI 476/5-2: Influenza during pregnancy and consequences for mother and child (2018-2023) SFB 1192 A04: Autoreactive T cell responses in glomerulonephritis (2016-2019) MI 476/7-1: Role of Interferon Regulatory Factor 4 in T cell memory (2017-2021) His laboratory investigates T cell responses using sophisticated mouse models of infection and autoimmunity, with particular expertise in analyzing small T cell populations and their functional properties. Current research directions include understanding how pregnancy alters antiviral immunity, mechanisms of tissue-resident memory T cells, and the role of specific ion channels and signaling molecules in T cell function.

Maria da Conceição PereiraView profile

Lecturer

• Data Science
• Data Mining
• Text Mining
• +9 more

Maria da Conceição Pereira is a Lecturer in Operating Systems and Virtualization at ISCTE-Sintra (School of Applied Technologies) and a Research Assistant at ISTAR-Iscte, ISCTE-IUL's R&D unit. She is pursuing a PhD in Information Sciences and Technologies at ISCTE-IUL while maintaining her teaching and research roles. Academic Career : Guest lecturer since 2020, teaching Operating Systems and Virtualization (2022-2024) and Fundamentals of Computer Architecture (2020-2021). PhD Research : Focused on data science, IoT, and decision support systems. Research Areas : Data Mining, Text Mining, Sentiment Analysis, Advanced Computer Architectures, and Matlab/Simulink applications. Academic Production Trends : Her recent work emphasizes smart city technologies , data-driven incident management , and pedagogical innovation in computer science education. She has also contributed to food science (bioactive delivery), agricultural technology, and clinical research. Key Projects : Managed communications for the Fish2Fork project (EEA Grants) and co-organized ISCTE's IoT lab initiatives. Advising : Co-orientated student projects at ISCTE's Summer School (2021). Technical Expertise : Over 30 years of experience in IT consultancy, programming, and training in electronics, control systems, and telecommunications.

William C. HahnView profile

Professor

• Cancer Biology
• Functional Genomics
• Precision Oncology
• +7 more

Dr. William C. Hahn is the William Rosenberg Professor of Medicine in the Department of Medical Oncology at Harvard Medical School and Dana-Farber Cancer Institute. He is also an Institute Member at the Broad Institute of MIT and Harvard. In addition to his academic roles, he serves as Executive Vice President and Chief Operating Officer at Dana-Farber, highlighting his leadership in both research and administration. His research focuses on the molecular basis of cancer, particularly using functional genomics to identify and validate therapeutic targets. The Hahn Lab has developed systematic approaches to map cancer dependencies, study mutational processes, and understand resistance mechanisms in cancers such as pancreatic and lung cancer. Dr. Hahn’s recent publications reveal a strong emphasis on cancer dependency mapping, mutational landscapes (especially in TP53 and KRAS ), tumor metabolism, and the impact of the microenvironment on therapy response. His work integrates large-scale genomic data with experimental validation, contributing to initiatives like the Cancer Dependency Map and the Cancer Cell Line Encyclopedia. His scientific honors include: Wilson S. Stone Award (2000) Howard Temin Award (2001) Ho-Am Prize in Medicine (2010) Richard and Hinda Rosenthal Award from AACR (2015) Claire and Richard Morse Award (2019) Hope Funds Award of Excellence in Medicine (2023) He has been elected to the National Academy of Medicine, the American Society for Clinical Investigation, and the National Academy of Inventors. Dr. Hahn has led major collaborative grants and research networks, including the Cancer Target Discovery and Development Network. He mentors a large research team and contributes to training the next generation of cancer scientists. His lab, the Hahn Lab, is actively engaged in developing preclinical models and functional genomic tools to accelerate precision oncology.

• Environmental Epidemiology
• Nutritional Genomics
• Pediatric Asthma
• +3 more

Anna Bergström is a Professor at the Institute of Environmental Medicine , Karolinska Institute, leading research on environmental and nutritional influences on asthma, allergies, and cardiometabolic health across the lifespan. Her work focuses on the BAMSE cohort , tracking 4,089 children since 1994-1996 to understand early-life determinants of chronic disease. Research Themes : Environmental exposure (air pollution, tobacco, PAHs), nutritional factors (PUFAs, antioxidants, dietary patterns), and allergic disease trajectories from infancy to young adulthood. Key Collaborations : European Respiratory Journal, Allergy, Nutrients, and Thorax publications with multidisciplinary teams across Sweden, Finland, and Canada. Recent Focus : Long-COVID sequelae in young adults, obesity-asthma interactions, and policy impacts on allergy management (e.g., co-payment removal for epinephrine autoinjectors). Article Trends (2019-2025): Longitudinal analysis of BAMSE , MeDALL , and ADVANCE cohorts; integration of proteomics, epigenetics, and metabolomics to dissect environmental-immune interactions; emphasis on cardiometabolic markers in allergic patients and socioeconomic disparities in disease management.

Nicola Alexander HananiaView profile

Professor

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Airway Pharmacology
• +7 more

Nicola Alexander Hanania, M.D., M.S., is a Professor in the Department of Medicine at Baylor College of Medicine, Houston, Texas. He serves as Director of the Airways Clinical Research Center and Chief of Pulmonary/Critical Care/Sleep Medicine at Ben Taub Hospital. He is also Editor-in-Chief of Respiratory Medicine and Associate Editor for the asthma section of Current Opinion in Pulmonary Medicine . MBBS, University of Jordan (1984) Internal Medicine Residency, University of Jordan Pulmonary & Critical Care Residency, University of Toronto MSc in Clinical Investigations, Baylor College of Medicine (2010) Dr. Hanania is a leading expert in asthma and COPD, with a research focus on airway pharmacology, clinical trials, and precision therapy. His work bridges translational science and clinical application, aiming to develop new treatments for chronic respiratory diseases. His interests include bronchodilators, biomarkers, and the role of biologics in severe asthma and COPD. His recent publications reflect a strong trend in evaluating biologic therapies such as dupilumab and tezepelumab for COPD and asthma, understanding inflammatory phenotypes, and refining diagnostic tools like FeNO. He has led and contributed to numerous clinical trials and consensus guidelines in respiratory medicine. Scientific Awards and Honors: Fellow of European Respiratory Society (FERS) Thomas Petty, MD, Master ACCP Memorial Lectureship in COPD Distinguished Scholar in Respiratory Health (ACCP) Career Investigator Award (K23), NIH/NHLBI Fulbright and Jaworski Faculty Excellence Award for Teaching (Baylor) Multiple teaching and humanitarian awards Listed in Marquis Who's Who in America Dr. Hanania has received research funding from the American Lung Association, NIH, and industry sponsors. He leads a large research team involved in multi-center collaborative trials. He is actively involved in mentoring and faculty development, having been a member of the Academy of Distinguished Educators at Baylor College of Medicine. He oversees the Airways Clinical Research Center, which conducts single- and multi-center clinical trials focused on asthma and COPD. The center is a hub for translational research and innovation in respiratory therapeutics.

• Cancer Metabolism
• Clinical Biochemistry
• Oxidative Stress
• +3 more

Prof. Dr. Türkan Yiğitbaşı is a Professor in the Department of Medical Biochemistry at Istanbul Medipol University's School of Medicine, where she has held a faculty position since 2012. She serves as the director of the university's Genetic Evaluation Center, accredited under ISO 15189 standards. Dr. Yiğitbaşı graduated from Ege University Faculty of Medicine in 1988 and completed her specialization in Biochemistry and Clinical Biochemistry at Erciyes University in 1994. Earlier in her career (1996–2002), she established and managed clinical laboratories, and she conducted research at Baylor College of Medicine (2002–2004). Her research focuses on cancer metabolism , clinical biochemistry , and oxidative stress , with significant work in biomarker discovery, reproductive biology, and metabolic disorders. She investigates molecular mechanisms in cancer, endocrine function, and environmental toxicology using models ranging from cell lines to zebrafish embryos. Analysis of her 15 most recent publications reveals dominant themes: cancer therapeutics (breast, prostate, colorectal, lung), oxidative stress biomarkers in diseases, reproductive biochemistry (infertility, minipuberty), and molecular mechanisms of metabolic enzymes (LDH, NOX5). Her work bridges clinical applications with experimental pharmacology. Dr. Yiğitbaşı leads the Genetic Evaluation Center, which supports clinical diagnostics and research. No grants, awards, or student advisement details were available in the provided text.

• Immunology
• Medical Microbiology
• Paediatrics and Reproductive Medicine
• +3 more

Cecilia Johansson is a Professor of Mucosal Immunology at the National Heart & Lung Institute, part of the Faculty of Medicine at Imperial College London. Her academic journey includes undergraduate studies at Umeå and Lund Universities (Sweden), a PhD in Immunology from Lund University, and postdoctoral training at the NIH, USA. She leads a research group investigating immunity during viral infections, particularly focusing on type I interferons' role in lung inflammation and cancer interactions. Her affiliations include the Asthma UK Centre for Asthma and Allergy, the Immuno-Pathology Network, and the Imperial Network for Vaccine Research. She organizes the Imperial CREST Academy, fostering science education for students aged 16-18. Her work is supported by grants from MRC, BBSRC, Wellcome Trust, and others. Research interests span mucosal immunology, viral pathogenesis, T cell responses, and innate immunity. Her lab explores how viral infections influence lung cancer progression and develops vaccine strategies using lentiviral and AAV vectors. Recent studies highlight the interplay between neutrophils, cytokines, and viral outcomes in RSV and SARS-CoV-2 models.

• Clinical Sciences
• Cardiorespiratory Medicine and Haematology
• Biochemistry and Cell Biology
• +3 more

Graeme Birdsey is an Associate Professor in Vascular Science at the National Heart & Lung Institute, part of Imperial College London's Faculty of Medicine. His research focuses on transcriptional and epigenetic regulation of endothelial cell gene expression in angiogenesis and lymphangiogenesis. He has held affiliations with the CDT in Chemical Biology, the Institute of Chemical Biology, the Stem Cell Regenerative Medicine Network, and the Vascular Science Network. Dr. Birdsey earned a BSc in Applied Biochemistry from Liverpool John Moores University and a PhD in Molecular Cell Biology from University College London (UCL). His postdoctoral training included work in Prof. Chris Danpure's lab (UCL) on alanine:glyoxylate aminotransferase (AGT) targeting, followed by studies on nitric oxide regulation under Prof. Patrick Vallance at UCL. His research spans vascular biology, with emphasis on ERG transcription factor roles in endothelial cell function, vascular inflammation, and disease mechanisms. Key areas include lymphatic malformations, cardiovascular diseases, and genetic syndromes linked to ERG mutations. His work integrates molecular biology, genomics, and 3D modeling approaches. Publications highlight contributions to vascular biology, including ERG's role in angiogenesis regulation, therapeutic strategies using ultrasound-microbubble systems, and genetic insights into rare diseases. His research bridges basic science and clinical applications in cardiovascular and inflammatory disorders.

• Cell Mechanics
• Tissue Dynamics
• Mechanobiology
• +4 more

Raimon Sunyer Borrell is a Researcher at the Institute for Bioengineering of Catalonia (IBEC), where he leads investigations within the Integrative Cell and Tissue Dynamics group. His work bridges biophysics, bioengineering, and cell biology to decipher how mechanical forces govern cellular and tissue behavior in physiological and pathological contexts. His primary research focuses on mechanobiology, particularly collective cell migration, durotaxis (stiffness-guided migration), and tissue dynamics. He investigates how cells sense mechanical cues through adhesion complexes like E-cadherin, with applications in understanding developmental processes, sleep apnea pathophysiology, and circadian rhythm disruptions. His interdisciplinary approach combines advanced experimental techniques—including atomic force microscopy, microfluidic platforms, and 3D tissue models—with computational modeling to quantify force transmission and tissue remodeling. Analysis of his 15 most recent publications reveals consistent innovation in developing physiomimetic models for disease study (e.g., intermittent hypoxia systems for sleep apnea) and fundamental discoveries about collective cell behaviors. His work demonstrates how mechanical coordination across cell clusters enables optimal migration through complex environments, with implications for regenerative medicine and tissue engineering. Dr. Sunyer actively contributes to IBEC's collaborative ecosystem, working within the Integrative Cell and Tissue Dynamics group that develops cutting-edge tools for probing cellular mechanics. His research directly supports IBEC's mission to translate fundamental discoveries into biomedical applications through interdisciplinary collaboration.

Kamal M. KhannaView profile

Associate Professor

• Macrophages
• CD8 T cells
• Infections
• +3 more

Kamal M. Khanna is an Associate Professor in the Department of Microbiology at New York University Grossman School of Medicine. His research explores the intersection of immunology and microbiology, focusing on macrophage dynamics, CD8 T cell responses, and immune regulation during infections and tumor development. PhD from University of Pittsburgh His work spans viral immunity (e.g., influenza and SARS-CoV-2), antimicrobial resistance, and tumor immunology, with recent publications examining lung myeloid cell regulation and immunotherapy resistance mechanisms. Selected publications highlight his expertise in: Neuro-immune interactions in viral infections Metabolic stress and immune compromise Targeting glutamine metabolism in cancer Helminth infection immunodynamics Tumor microenvironment regulation KEAP1 mutation-driven immune evasion The Khanna Lab at NYU Langone Health trains students and fellows in microbiology and immunology, with current PhD students including Mimi Kostoska and Heemaja Mewada. His lab is located at 430 East 29th Street, New York City.

• Epigenetics
• Transcriptional Regulation
• Cancer Research
• +3 more

Simon Toftholm Jakobsen is a Postdoctoral Researcher in the Department of Biochemistry and Molecular Biology at the University of Southern Denmark, specializing in Functional Genomic Studies and Metabolism. His research focuses on epigenetic mechanisms and transcriptional regulation with significant implications for cancer biology. Dr. Jakobsen's research spans several interconnected domains: Epigenetic regulation of gene expression Transcriptional enhancer and promoter dynamics MYC oncogene function in cancer progression DNA methylation and demethylation processes Single-cell resolution of transcriptional regulation Carcinogenesis mechanisms His recent publications demonstrate a strong focus on how epigenetic mechanisms influence cancer development, particularly examining MYC's role in regulating transcription through enhancer regions and how epigenetic modifications affect cancer cell behavior. His work bridges fundamental molecular mechanisms with potential therapeutic applications in oncology. Dr. Jakobsen is actively involved in research funding, currently participating in the project 'Transcriptional regulation at single-cell resolution' (2022-2027), which investigates enhancer regions, epigenetics, transcription, and demethylation using advanced single-cell approaches. His research has received significant attention, with multiple media features in March 2024 highlighting new insights into cancer cell growth and spread, suggesting potential targets for future cancer treatments.

Sana KoubaView profile

Assistant Professor

• Calcium Signaling
• Cancer Biology
• T Cell Function
• +2 more

Sana Kouba is an Assistant Professor at the University of Geneva , affiliated with the Intracellular Signals Research Group . Her work focuses on calcium signaling mechanisms in cancer progression and immune cell regulation. University: University of Geneva Role: Assistant Professor Email: Tamara.Bollmann@unige.ch Her research explores: Calcium signaling in cancer cell survival and metastasis Ion channel regulation via lipid modifications Role of calcium transporters in tumor microenvironment adaptation Interactions between calcium signaling and stemness in drug resistance Recent publications (2024-2025) highlight her work on genomic interrogation of calcium homeostasis, S-acylation of Ca2+ transport proteins, and functional roles of ion channels like TRPC1 and Orai3 in pancreatic, prostate, and breast cancers. Earlier works (2013-2020) span molecular spectroscopy and lipidic modulators of ion channels. Scientific Awards : No awards listed in provided data. Advising & Grants : No specific students, grants, or labs mentioned in scraped content.

Abdullah K. AlismailView profile

Associate Professor

• Respiratory Tract Diseases
• Critical Care
• Pulmonology
• +11 more

Abdullah K. Alismail is an Associate Professor in the Department of Medicine at the School of Medicine and Associate Chair in the Department of Cardiopulmonary Sciences at the School of Allied Health Professions, Loma Linda University. He holds a PhD from Claremont Graduate University and multiple advanced degrees in health sciences, with a strong clinical background as a Registered Respiratory Therapist (RRT-NPS, RRT-SDS), and is recognized as a Fellow of the American College of Chest Physicians (FCCP) and Fellow of the American Association for Respiratory Care (FAARC). PhD, Claremont Graduate University (2021) MA, Claremont Graduate University (2017) MS, Loma Linda University (2012) BS, Loma Linda University (2014, 2010) His research spans respiratory care, critical care, asthma management, pulmonary function testing, and medical education. He investigates biologic therapies in asthma, bronchial thermoplasty, hyperbaric oxygen therapy, and simulation-based learning. His work emphasizes clinical education innovation, cognitive load theory, and interprofessional collaboration. He actively publishes in journals such as Advances in Medical Education and Practice , Respiratory Medicine , and BMC Pulmonary Medicine . His recent publications (2023–2025) focus on advanced respiratory therapy practices, elderly asthma management, point-of-care lung ultrasound adoption, ventilatory strategies in critical care, and educational innovations in resource-limited settings. Themes include clinical decision-making, patient outcomes, simulation effectiveness, and healthcare disparities. He has received notable scientific recognition including: Fellow of the American College of Chest Medicine (2022) RCP of the Year, Inland Empire Region, CSRC (2022) Dr. Alismail serves as Principal Investigator and co-investigator on multiple grants related to asthma, pulmonary rehabilitation, simulation training, and diagnostic techniques. He mentors students through capstone and research projects, teaches a wide range of courses in respiratory therapy, and contributes to curriculum development. He is an Associate Editor for BMC Pulmonary Medicine and serves on the board of the Coalition for Baccalaureate and Graduate Respiratory Therapy Education (CoBGRTE). He leads or participates in research labs and teams focused on simulation-based education, respiratory physiology, and clinical outcomes in pulmonary diseases. His lab work includes the use of augmented reality in training, wearable manikins, and evaluation of ventilatory techniques. He is actively involved in interprofessional education initiatives at Loma Linda University.

Christina Katharina WeisheitView profile

Researcher

• Immunology
• Cardiovascular Diseases
• Aortic Valve Stenosis
• +12 more

PD Dr. Christina Katharina Weisheit is a Consultant Anesthesiologist and Principal Investigator at the Department of Anesthesiology and Intensive Care Medicine, Medical Faculty, University of Bonn, and will move to the University Hospital Cologne in February 2025. She leads the Weisheit Research Group and is a co-Principal Investigator in the SFB TRR259 project. She is a member of the Excellence Cluster Immunosensation2 and the ACCENT Program for Advanced Clinician Scientists. Research Interests: Her research focuses on elucidating the immunological and molecular mechanisms underlying aortic valve stenosis, left ventricular hypertrophy, and infective endocarditis. She investigates the roles of aging, the gut microbiome, and epigenetic modifications in immune dysfunction during critical illness. Her group employs advanced techniques including multiparameter FACS, immunofluorescence microscopy, and molecular biology. A key translational goal is the development of nanoparticle-based drug delivery systems for targeted therapy in cardiovascular diseases and the identification of novel biomarkers for early detection and treatment. Publication Trends: Her recent publications span from basic immunology (e.g., neutrophil function, macrophage subsets) to clinical-translational research (e.g., anesthetic management in aortic stenosis, sustainability in surgery). A strong theme is the interplay between immunity and cardiovascular pathology, with increasing focus on microbiome influences, aging, and epigenetic regulation in sepsis and cardiac remodeling. Her work bridges experimental models with human patient samples. Scientific Awards and Memberships: Member, Excellence Cluster Immunosensation2 Member, ACCENT Program Bonn for Advanced Clinician Scientists Advising and Grants: She mentors a diverse team including doctoral candidates, master's students, and medical researchers. Her research is supported by competitive third-party funding, including a DFG individual grant (Project Number: 535107899), a subproject in SFB TRR259 (Project A01), and funding from DLR for the CovidDataNet.NRW project at the Bonn site. Labs and Teams: She leads the AG Weisheit research group at the University Hospital Bonn, which is embedded within the Institute for Experimental Immunology and Molecular Medicine. Her team collaborates extensively with cardiology, microbiology, and immunology experts across Bonn, Cologne, and internationally (e.g., Harvard Medical School). Her lab focuses on translational cardiovascular immunology and is part of a larger interdisciplinary network investigating aortic diseases.